Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 171.46M
March 31, 2026 126.24M
December 31, 2025 97.34M
September 30, 2025 84.89M
June 30, 2025 83.43M
March 31, 2025 82.39M
December 31, 2024 81.52M
September 30, 2024 80.67M
June 30, 2024 76.40M
March 31, 2024 75.48M
December 31, 2023 73.35M
September 30, 2023 67.94M
June 30, 2023 63.53M
March 31, 2023 59.59M
December 31, 2022 56.70M
September 30, 2022 55.46M
June 30, 2022 51.49M
March 31, 2022 48.34M
December 31, 2021 42.88M
Date Value
September 30, 2021 35.00M
June 30, 2021 27.55M
March 31, 2021 15.79M
December 31, 2020 8.746M
September 30, 2020 1.647M
June 30, 2020 -1.072M
March 31, 2020 -0.921M
December 31, 2019 -0.528M
September 30, 2019 -0.179M
June 30, 2019 -0.886M
March 31, 2019 -0.84M
December 31, 2018 -0.726M
September 30, 2018 -0.635M
June 30, 2018 7.654M
March 31, 2018 7.521M
December 31, 2017 7.47M
September 30, 2017 7.43M
June 30, 2017 -0.087M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Xencor, Inc. 94.79M
MeiraGTx Holdings Plc 377.25M
Insmed, Inc. 941.78M
Ironwood Pharmaceuticals, Inc. 387.48M
Viking Therapeutics, Inc. -0.45M